12

News

Johan Wäborg presenterar Iconovo på Aktiedagen

Iconovo utvecklar och förnyar inhalation av läkemedel och vaccin Iconovo utvecklar och förnyar inhalation av läkemedel och vaccin. Många…
Read more

Meet us at CPHI, November 1-3

Read more

Johan Wäborg, VD i Sveriges Radio om samarbete för bättre läkemedel

Read more

PRODUCTS

Four differentiated technical platforms, available for customization

Iconovo offers the development of inhalation products — inhaler devices and dry powder formulation — and assists in clinical trials and registration. We also offer proprietary generic drugs. The inhalation platforms are primarily intended for asthma and chronic obstructive pulmonary disease (COPD) treatment.

Learn more…

SERVICES

Seeking a fast and safe way to reach the market?

We work with international generic drug companies and pharmaceutical companies that lack the expertise, resources and/or time to develop the product themselves. Our development time is shorter and consequently more cost-effective since we have ready-to-use platforms with inhalation products that can be modified for a specific drug.

Learn more…

CAPABILITIES

A unique combination of engineering and pharmaceutical expertise

Iconovos highly skilled employees offers a comprehensive service package including device design, formulation development, analytical testing and documentation. Iconovo has build its own state-of-the-art laboratories for analysis, development and characterization of powder formulations.
Learn more…

Read more about our customer collaborations

Want to know when we got news on our platforms? Sign up for our press releases now!